1. Home
  2. UMH vs AMPH Comparison

UMH vs AMPH Comparison

Compare UMH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UMH

UMH Properties Inc.

HOLD

Current Price

$16.00

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.84

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
AMPH
Founded
1968
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
UMH
AMPH
Price
$16.00
$26.84
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$17.75
$31.00
AVG Volume (30 Days)
602.7K
380.2K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
5.64%
N/A
EPS Growth
N/A
N/A
EPS
0.08
2.27
Revenue
$256,272,000.00
$723,305,000.00
Revenue This Year
$10.80
$1.35
Revenue Next Year
$8.34
$5.10
P/E Ratio
$203.36
$11.95
Revenue Growth
8.96
N/A
52 Week Low
$13.95
$20.39
52 Week High
$19.14
$39.01

Technical Indicators

Market Signals
Indicator
UMH
AMPH
Relative Strength Index (RSI) 61.01 53.45
Support Level $15.58 $26.26
Resistance Level $16.39 $27.44
Average True Range (ATR) 0.27 0.79
MACD -0.01 0.06
Stochastic Oscillator 70.19 74.12

Price Performance

Historical Comparison
UMH
AMPH

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: